Cargando…

Helicobacter pylori: Infection and New Perspective for the Treatment

Detalles Bibliográficos
Autores principales:	Fasciana, Teresa, Di Carlo, Paola, Jouini, Ahlem, Di Giulio, Mara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701331/ https://www.ncbi.nlm.nih.gov/pubmed/31467624 http://dx.doi.org/10.1155/2019/9431369

Ejemplares similares

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Helicobacter pylori and Epstein–Barr Virus Infection in Gastric Diseases: Correlation with IL-10 and IL1RN Polymorphism
por: Teresa, Fasciana, et al.
Publicado: (2019)

Searching for New Tools to Counteract the Helicobacter pylori Resistance: The Positive Action of Resveratrol Derivatives
por: Di Fermo, Paola, et al.
Publicado: (2020)

Helicobacter pylori Dormant States Are Affected by Vitamin C
por: Di Fermo, Paola, et al.
Publicado: (2023)

Helicobacter pylori Infection and Upper Gastrointestinal Disorders
por: Kate, Vikram, et al.
Publicado: (2013)

Self-Medication With Analgesics and Helicobacter pylori Infection
por: Metanat, Maliheh
Publicado: (2015)

Helicobacter pylori infection and osteoporosis in elderly patients
por: Heidari, Behzad
Publicado: (2015)

Helicobacter pylori and Pathogenesis
por: Tomoda, Akio, et al.
Publicado: (2015)

Spread of Multidrug-Resistant Microorganisms
por: Di Lodovico, Silvia, et al.
Publicado: (2022)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study
por: Ciccaglione, Antonio Francesco, et al.
Publicado: (2019)

Refractory Helicobacter pylori treatment in resource‐limited settings
por: Mahadeva, Sanjiv
Publicado: (2023)

Immunological Perspective: Helicobacter pylori Infection and Gastritis
por: Yang, Hang, et al.
Publicado: (2022)

Prevalence of Helicobacter pylori Infection in Patients with Chronic Kidney Disease
por: Ahn, Ji Yong
Publicado: (2019)

Are proton pump inhibitors a double-edged sword in the treatment of Helicobacter pylori infection?
por: Ge, Ruiguang
Publicado: (2012)

Special Issue “Extragastric Disorders of Helicobacter pylori Infection: From Diagnosis to Treatment”: Editorial
por: Doulberis, Michael, et al.
Publicado: (2023)

Helicobacter pylori infection: old and new
por: Diaconu, S, et al.
Publicado: (2017)

Regulation of p53 by Helicobacter pylori
por: Zaika, Alexander, et al.
Publicado: (2012)

Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015)

Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan
por: Suzuki, Sho, et al.
Publicado: (2023)

Helicobacter Pylori: Indian perspective
por: Patnayak, Rashmi, et al.
Publicado: (2015)

Helicobacter pylori infection and gastroesophageal cancer: unveiling a Hamletic dilemma
por: Zullo, Angelo, et al.
Publicado: (2014)

Progress in elucidating the relationship between Helicobacter pylori infection and intestinal diseases
por: Fujimori, Shunji
Publicado: (2021)

Role of potassium-competitive acid blockers in eradication of Helicobacter pylori infection
por: Kim, Tae Ho
Publicado: (2023)

Special issue: Helicobacter pylori
por: Peek, Richard M
Publicado: (2013)

Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains
por: Di Lodovico, Silvia, et al.
Publicado: (2019)

Treatment of Pediatric Helicobacter pylori Infection
por: Lai, Hung-Hsiang, et al.
Publicado: (2022)

Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
por: Ierardi, Enzo, et al.
Publicado: (2017)

The Pros and Cons of Helicobacter pylori Treatment: A Focus on Cardiovascular Mortality
por: Huh, Cheal Wung, et al.
Publicado: (2020)

Strategies for Helicobacter pylori eradication in the year 2020
por: Pellicano, Rinaldo, et al.
Publicado: (2020)

Inflammation at the crossroads of Helicobacter pylori and COVID-19
por: Gonzalez, Ileana, et al.
Publicado: (2021)

Role of Tegoprazan in Helicobacter pylori Eradication Therapy
por: Lee, Jin
Publicado: (2022)

Guided Treatment of Helicobacter pylori Infections with Non-Invasive PCR Tests—The Glory Days of Primary Care?
por: Pichon, Maxime, et al.
Publicado: (2022)

Helicobacter pylori treatment: antibiotics or probiotics
por: Goderska, Kamila, et al.
Publicado: (2017)

Probiotics as Dietary Supplements for Eradication of Helicobacter pylori Infection in Children: A Role Beyond Infection
por: Hassan, Sherif T. S., et al.
Publicado: (2016)

There Is No Reason to Delay Helicobacter pylori Eradication after Treatment for Upper Gastrointestinal Bleeding
por: Lee, Sun-Young
Publicado: (2015)

Relationship between Helicobacter pylori infection and GERD
por: Serena, Scida, et al.
Publicado: (2018)

Helicobacter pylori infection in India from a western perspective
por: Thirumurthi, Selvi, et al.
Publicado: (2012)

Current and Future Perspectives in the Diagnosis and Management of Helicobacter pylori Infection
por: Shatila, Malek, et al.
Publicado: (2022)

Helicobacter pylori and gastric cancer: time for mega-trials?
por: Danesh, J
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_uqc2ml7i3tgp166231vh24mq3o